Trump thinks Canadians are ‘mean and nasty' for boycotting U.S. travel, booze: Ambassador
That's the view of U.S. President Donald Trump, his ambassador to Canada told a Washington state audience on Monday morning — comments that drew a rebuke from B.C. Premier David Eby.
2:12
Trump's tariffs on Canada might be here to stay, U.S. Secretary of Commerce says
Pete Hoesktra was speaking at the PNWER summit in Bellevue, Wash., when an audience member asked him about Canadians eschewing travel south of the border in the context of the upcoming FIFA 2026 World Cup.
Story continues below advertisement
'That's their business — I don't like it, but if that's what they want to do, that's fine. They want to ban American alcohol; that's fine. It doesn't necessarily send real positive signals in terms of their treating us well,' Hokestra responded.
Get daily National news
Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day. Sign up for daily National newsletter Sign Up
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy
'There are reasons why the president and some of his team refer to Canada as being mean and nasty to deal with, OK, because of some of those steps.'
Hoekstra then drew laughs from the crowd when he said he has no problem getting U.S. liquor into Canada, as border officers don't check his vehicle when he crosses the border.
In a statement, Eby urged British Columbians to double down on their efforts to buy and travel within Canada in response.
5:51
Carney doubles down with counter tariffs
'Clearly, our efforts are having an impact,' Eby said. 'So, I say to my fellow Canadians: Keep it up. Keep buying Canadian. Keep your vacations Canadian. We won't take these attacks our jobs, our economy and our sovereignty, lying down. We'll stand strong together.'
Story continues below advertisement
A number of Canadian provinces, including British Columbia and Ontario, have pulled U.S. liquor from their shelves amid the trade dispute and Trump's repeated musings about making Canada the 51st state, potentially through the use of 'economic force.'
Canadian travel to the U.S. has also plummeted, with the number of visits by land and air falling for six consecutive months.
Earlier on Monday, a bipartisan delegation of U.S. senators travelled to Ottawa to plead with tourists to return to the U.S. and tell Canadians 'we miss you.'
Canada remains locked in intense negotiations with the United States over a new trade and security deal, and on Sunday, U.S. Commerce Secretary Howard Lutnick vowed that the tariffs on Canada were here to stay.
'The president understands that we need to open the markets. Canada is not open to us. They need to open their market. Unless they're willing to open their market, they're going to pay a tariff,' Lutnick told CBS's Face the Nation.
Trump has threatened a new 35 per cent tariff on Canadian products that would take effect on Aug. 1, along with a new 50 per cent tariff on copper and a 200 per cent tariff on pharmaceuticals.
Canada is already dealing with 25 per cent U.S. tariffs on steel and aluminum.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
28 minutes ago
- Cision Canada
Giyani Announces Non-Brokered Private Placement
, July 22, 2025 /CNW/ - Giyani Metals Corp. (TSXV: EMM) (GR: A2DUU8) (" Giyani" or the " Company"), developer of the battery-grade manganese project in Botswana (" or " the Project"), announces a non-brokered private placement of up to 50,000,000 units (each, a " Unit") at a price of $0.06 per Unit to raise aggregate gross proceeds of up to C$3 million (the " Offering"). Each Unit will be comprised of one common share in the capital of the Company (each, a " Common Share") and one-half of one Common Share purchase warrant (each whole warrant, a " Warrant") of the Company. Each Warrant shall entitle the holder thereof to acquire one Common Share at a price of $0.085 per Common Share for a period of 36 months from the closing date of the Offering. The Company expects to pay finder's fees in connection with the Offering to certain eligible finders in the form of: (i) a cash commission of 6.0% of the gross proceeds raised under the Offering from investors introduced to the Company by the finder; and (ii) the issuance of such number of non-transferable common share purchase warrants of the Company (the " Finder's Warrants") equal to 6.0% of the Units issued under the Offering from investors introduced to the Company by the finder. All securities issued or made issuable pursuant to the Offering will be subject to a hold period of four months plus a day from the date of issuance under applicable Canadian securities laws in addition to such other restrictions as may apply under applicable securities laws of jurisdictions outside Canada. Closing of the Offering is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals, including the approval of the TSX Venture Exchange. Highlights Non-brokered private placement of up to 50,000,000 Units at a price of $0.06 per Unit for aggregate gross proceeds of up to C$3 million. The proceeds of the Offering will continue to support Company workstreams, activities and general working capital. The Issue Price represents a 20% discount to the most recent closing price of the Common Shares. The Company is in ongoing discussions with offtakers for battery-grade manganese products, including high-purity manganese oxide (" HPMO") and high-purity manganese sulphate monohydrate (" HPMSM"). The Demo Plant is currently on track to produce HPMSM in Q3 2025. The Definitive Feasibility Study remains on track for completion in Q1 2026. Members of the board and senior management are expected to participate in the Offering. As a result of the expected participation in the Offering by certain directors and officers of the Company, the Offering is expected to be a related party transaction subject to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company expects to rely on exemptions from the formal valuation and minority shareholder approval requirements provided under sections 5.5(a) and 5.7(1)(a) of MI 61-101 on the basis that participation in the Offering by such directors and officers is not expected to exceed 25% of the fair market value of the Company's market capitalization. Charles FitzRoy, President and CEO of the Company, commented: " We are pleased with the support shown thus far by new and existing investors, which reflects confidence in our long-term strategy to deliver sustainable, low-carbon high-purity battery grade manganese products for the EV and ESS industries. This financing will provide us with the flexibility and resources needed to capitalize on upcoming growth opportunities, including producing HPMSM from the Demo Plant this quarter, delivering the Definitive Feasibility Study next year, and positioning the Company to progress towards Project Financing." Demo Plant Commissioning and Production Update The production ramp-up phase (C5 Commissioning) continues to advance, and the team continues to work progressively towards first production of HPMSM in Q3 2025. The learnings from the Demo Plant will support further optimization of the anticipated design and engineering, and process flowsheet, which aims to reduce the Commercial Plant's operating cost and carbon profile. The inputs from the Demo Plant operations will be used in the Definitive Feasibility Study, which is currently underway and expected to be completed in Q1 2026. Manganese Market The demand for manganese is set to rise significantly, driven by advancements in battery technologies that increasingly favour higher manganese content owing to its stabilising properties. From 2028 onwards, new battery chemistries being developed will require greater quantities of high-purity manganese sulphate monohydrate (HPMSM) and high-purity manganese oxide (HPMO) as critical inputs. 1 This shift in demand is largely attributed to the growing adoption of electric vehicles and energy storage solutions, both of which rely on next-generation batteries with enhanced performance and safety profiles. Giyani is uniquely positioned to capitalize on this market evolution. The Company benefits from assets located in a supportive jurisdiction, enabling it to align its project timelines with the anticipated surge in demand for HPMSM and HPMO. Qualified Persons / NI 43-101 Disclosures A National Instrument 43-101 (" NI 43-101") technical report including results of the PEA and the MRE can be found on SEDAR+ at and made available on the Company's website at Jeffrey Peter Stevens BSc (Chem Eng) Pr. Eng is a Qualified Person, as defined by NI 43-101. Mr. Stevens is assisting the Company for DFS compliance with NI 43-101 and has reviewed and approved the scientific and technical content contained in this news release and is independent of the issuer for the purposes of NI 43-101. About Giyani Giyani is focused on becoming a preferred western-world producer of sustainable, low carbon high purity battery grade manganese for the EV and ESS industry. The Company has developed a proprietary hydrometallurgical process to produce battery-grade manganese (HPMSM and HPMO), a lithium-ion battery cathode precursor material critical for EVs and ESS. Additional information and corporate documents may be found on Giyani Metals Corp. website at On behalf of the Board of Directors of Giyani Metals Corp. Charles FitzRoy, President and CEO This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the " 1933 Act"), or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available. Neither the TSX Venture Exchange (the "TSXV") nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release. Forward Looking Information This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. All statements in this news release, other than statements of historical fact, that address events or developments that Giyani expects to occur, are "forward-looking statements". Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "does not expect", "plans", "anticipates", "does not anticipate", "believes", "intends", "estimates", "projects", "potential", "scheduled", "forecast", "budget" and similar expressions, or that events or conditions "will", "would", "may", "could", "should" or "might" occur. All such forward-looking statements are based on the opinions and estimates of the relevant management as of the date such statements are made and are subject to certain assumptions, important risk factors and uncertainties, many of which are beyond Giyani's ability to control or predict. Forward-looking statements are necessarily based on estimates and assumptions that are inherently subject to known and unknown risks, uncertainties and other factors that may cause actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. In the case of Giyani, these facts include the Company's anticipated use of proceeds and the use of the net proceeds following closing of the Offering and statements respecting closing of the Offering and receipt of all regulatory approvals in respect of the Offering, including approval of the TSXV, as well as anticipated operations in future periods, planned construction and development of its properties and facilities, and plans related to its business and other matters that may occur in the future. This information relates to analyses and other information that is based on expectations of future performance and planned work programs. Forward-looking information is subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking information, including, without limitation: inherent exploration hazards and risks; risks related to exploration and development of natural resource properties; uncertainty in Giyani's ability to obtain funding; commodity price fluctuations; recent market events and conditions; risks related to governmental regulations; risks related to obtaining necessary licences and permits; risks related to Giyani's business being subject to environmental laws and regulations; risks related to the Company's mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to competition from larger companies with greater financial and technical resources; risks relating to the inability to meet financial obligations under agreements to which they are a party; ability to recruit and retain qualified personnel; and risks related to the Company's directors and officers becoming associated with other natural resource companies which may give rise to conflicts of interests. This list is not exhaustive of the factors that may affect Giyani's forward-looking information. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking information or statements. Giyani's forward-looking information is based on the reasonable beliefs, expectations and opinions of the Company's respective management on the date the statements are made, and Giyani does not assume any obligation to update forward looking information if circumstances or management's beliefs, expectations or opinions change, except as required by law. For the reasons set forth above, investors should not place undue reliance on forward-looking information. For a complete discussion with respect to Giyani and risks associated with forward-looking information and forward-looking statements, please refer to Giyani's continuous disclosure documents which are filed on SEDAR+ at
Cision Canada
28 minutes ago
- Cision Canada
OceanaGold Announces Renewal of Share Buyback
VANCOUVER, BC, July 22, 2025 /CNW/ - OceanaGold Corporation (TSX: OGC) (OTCQX: OCAND) ("OceanaGold" or the "Company") announces it has received approval from the Toronto Stock Exchange ("TSX") to renew its Normal Course Issuer Bid ("NCIB"), permitting the Company to buy back up to approximately 23 million common shares ("Common Shares"), representing a maximum of 10% of the Company's public float over the next 12 months. As of July 21, 2025, there were a total of 231,121,129 Common Shares issued and outstanding. The Company believes that the market price of the Common Shares may not, from time to time, fully reflect their value and accordingly the repurchase of its Common Shares would be in the best interest of its shareholders. Over the prior 12 months under the current NCIB, OceanaGold has repurchased $65 million through the buyback, (6.85 million shares at an average price of C$13.06 per share on a post consolidation basis) with $41 million of the board approved $100 million for the full-year 2025 now completed. The remaining $59 million is expected to be deployed in the second half of 2025 under the renewed NCIB. The increased share repurchase limit provides the Company increased flexibility to continue share buybacks throughout the remainder of 2025 and the first half of 2026. Gerard Bond, President and Chief Executive Officer of OceanaGold, said "OceanaGold is operating from a position of financial strength, with robust Free Cash Flow generation and a strong balance sheet. In alignment with our disciplined capital allocation framework, we are pleased to announce a renewed NCIB program with an increased repurchase limit. This increased limit allows the Company to continue utilizing the share buyback program to return value to our shareholders while continuing to invest in our growth and exploration projects across the business." In connection with the NCIB, the Company has entered into an Automatic Share Purchase Plan ("ASPP") with a designated broker to allow for the repurchase of Common Shares at times when the Company ordinarily would not be active in the market due to its own internal trading blackout periods. The Company has received approval from the TSX, during the 12-month period commencing on July 24, 2025 and ending on or before July 23, 2026, to purchase up to approximately 23 million Common Shares through the facilities of the TSX and alternative Canadian trading systems. Under the terms of the NCIB, the Company may purchase up to a daily maximum of 180,933 Common Shares (being 25% of the average daily trading volume of 723,735 Common Shares for the six-month period ended June 30, 2025, in each case on a post-consolidation basis). The ASPP will terminate on the earliest of the date on which the: (i) purchase limit under the NCIB has been reached; (ii) NCIB expires; and (iii) ASPP otherwise terminates in accordance with its terms. The ASPP constitutes an "automatic plan" for purposes of applicable Canadian securities legislation and the agreement governing the plan has been pre-cleared by the TSX. The actual number of Common Shares that may be purchased and the timing of such purchases will be determined by the Company in accordance with applicable laws and the ASPP. Decisions regarding purchases will be based on market conditions, share price, best use of available cash, and other factors. Any Common Shares that are purchased under the NCIB will be cancelled. About OceanaGold OceanaGold is a growing intermediate gold and copper producer committed to safely and responsibly maximizing the generation of Free Cash Flow from our operations and delivering strong returns for our shareholders. We have a portfolio of four operating mines: the Haile Gold Mine in the United States of America; Didipio Mine in the Philippines; and the Macraes and Waihi operations in New Zealand. Cautionary Statement for Public Release This press release contains certain "forward-looking statements" and "forward-looking information" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities laws, which may include, but is not limited to, statements with respect to the amount of and timing for anticipated purchases under the NCIB and the ASPP. All statements other than statements of historical facts included in this press release constitute forward-looking statements. Forward-looking statements and information relate to future performance and reflect the Company's expectations regarding the generation of Free Cash Flow, execution of business strategy, future growth, future production, estimated costs, results of operations, business prospects and opportunities of OceanaGold and its related subsidiaries. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "estimates" or "intends", or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those expressed in the forward-looking statements. They include, among others, those risk factors identified in the Company's most recent Annual Information Form prepared and filed with securities regulators which is available on SEDAR+ at under the Company's name and on the Company's website. There are no assurances the Company can fulfil forward-looking statements. Such forward-looking statements are only predictions based on current information available to management as of the date that such predictions are made; actual events or results may differ materially as a result of risks facing the Company, some of which are beyond the Company's control. Although the Company believes that any forward-looking statements contained in this press release is based on reasonable assumptions, readers cannot be assured that actual outcomes or results will be consistent with such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements and information, whether as a result of new information, events or otherwise, except as required by applicable securities laws.
Cision Canada
28 minutes ago
- Cision Canada
Else Nutrition Applauds Pivotal U.S. Legislative Support for Plant-Based, Non-Soy, Non-Dairy Infant Formula Innovation
House Appropriations Committee Champions Greater Nutritional Choice and Market Access for U.S. Families FDA Directed to Streamline Approval Pathways for Plant-Based Infant Formulas, Positioning Else Nutrition to Capitalize on Legislative Momentum and Rising Consumer Demand VANCOUVER, BC, July 22, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the"Company"), a global leader in wholefood, plant-pased childhood nutrition for babies, toddlers, children and adults, today applauds the U.S. House of Representatives Committee on Appropriations for the full-committee passage of the FY2026 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill. This landmark legislation includes vital language recognizing the importance of expanding access to alternative infant formulas—specifically plant-based, non-soy, and non-dairy formulations—for a growing number of American families. The accompanying report directs the U.S. Food and Drug Administration (FDA) to streamline approval pathways for small domestic manufacturers and calls for formal regulatory guidance around non-dairy, non-soy plant-based formulas. These are critical for infants with allergies, intolerances, or sensitivities to traditional ingredients—as well as for families seeking nutritional alternatives aligned with health, lifestyle, or ethical values. "This marks a turning point for American families and for Else Nutrition," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "For too long, parents have had to choose between limited formula options that may not meet their child's needs. This legislative milestone signals that change is coming—toward a more inclusive and diversified infant formula landscape. We commend Congress for recognizing this urgent need and taking action that we believe will benefit families for generations to come." Although these types of advanced formulas have gained traction in global markets, regulatory delays have historically constrained innovation in the U.S. market. The recently advanced legislative language is a strong signal to the FDA to establish clear, actionable guidance that can accelerate the availability of safe, effective, and scientifically backed alternatives. The report also highlights the Operation Stork Speed initiative, part of the Administration's broader effort to fast-track innovation in the infant formula space. By elevating plant-based, non-dairy, non-soy formulations as a key component of this initiative, the legislation reinforces the national commitment to nutritional accessibility and product diversity. While additional legislative steps remain—including passage by the full House—the inclusion of this language in the committee's final report is a powerful indication of Congressional momentum. Though report language is non-binding, it frequently shapes agency priorities, resource allocation, and the pace at which new regulatory frameworks are developed. For Else Nutrition, the implications are clear: the path to broader U.S. market access is becoming more defined. "This is the clearest signal yet that U.S. policymakers are aligned with what we at Else have long championed—that every child deserves access to safe, effective, and nutritionally complete formula options," Yitzhak added. "We look forward to supporting this important public health mission by working with the FDA and other federal partners to help bring innovative solutions to more families, more quickly." DISCLAIMERS This grassroots lobbying effort is a statement of issue advocacy and does not require disclosure under the Lobbying Disclosure Act. This is not an electioneering statement, and this message has not been coordinated with any political parties or candidates. This message is paid for by Else Nutrition and is intended for only a "restricted class" of stockholders and administrators of the company. Whereas this is an instance of grassroots lobbying, Else Nutrition's engaged lobbying principals file disclosures required under the Lobbying Disclosure Act for direct lobbying services on behalf of the company. About Else Nutrition Holdings Inc. Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and Plant-Based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, Plant-Based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth. Awards and Recognition: "2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category "Best Dairy Alternative" Award 2021 at World Plant-Based Expo Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon TSX Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release. Caution Regarding Forward-Looking Statements This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company's financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. SOURCE Else Nutrition Holdings Inc.
